Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Maxi chloride channel, also known as the Maxi-anion channel (MAC), is a high-conductance (300–400 pS) voltage-dependent anion channel found in the plasma membrane of most mammalian cell types (Okada et al., 2019). For decades, its molecular identity remained elusive until recent studies identified the solute carrier organic anion transporter family member 2A1 (SLCO2A1) as its core component (Sabirov et al., 2017). The channel is activated by various stimuli, including cell swelling, hypoxia, and ischemia, playing a pivotal role in cell volume regulation and the release of ATP into the extracellular space (UniProt Q92959). This ATP release serves as a critical purinergic signal in processes such as inflammation, apoptosis, and cardiac protection. In disease contexts, the Maxi-Cl channel is implicated in ischemia-reperfusion injury and certain types of cancer, where its dysregulation affects cell survival and signaling (PubMed: 29042477). Pharmacological modulation of the channel is currently limited to non-specific inhibitors like NPPB and DIDS, which are primarily used in research settings (PubChem). Targeting this channel offers therapeutic potential for treating conditions involving excessive ATP release or impaired prostaglandin transport, though its ubiquitous expression poses significant challenges for drug specificity and safety.
Inhibition of high-conductance anion transport and ATP release from cells under stress conditions.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maxi chloride channel (Maxi-Cl).